Other Species / Isoforms
  SHCBP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MADGsLtGGGLE
Upstream
0 9
Regulatory protein:
  • PLK1 (human)
Treatment
  • nocodazole
  • ZK-Thiazolidinone
SHCBP1 (human) ___MADGsLtGGGLE S5-p
SHCBP1 (mouse) ___MADDLRAGGVLE L5
SHCBP1 (rat) ___MADDLQAGVVLE L5
T7-p
_MADGsLtGGGLEAA
Upstream
0 3
Treatment
  • nocodazole
SHCBP1 (human) _MADGsLtGGGLEAA T7-p
SHCBP1 (mouse) _MADDLRAGGVLEPI A7
SHCBP1 (rat) _MADDLQAGVVLEPD A7
S31-p
AVEQELAsLEKGLFQ
0 3
SHCBP1 (human) AVEQELAsLEKGLFQ S31-p
SHCBP1 (mouse) AAEKEPASWKEGLFL S31
SHCBP1 (rat) AAEEEPASWKEGLFQ S31
S42-p
GLFQDEDsCsDCsyR
0 17
SHCBP1 (human) GLFQDEDsCsDCsyR S42-p
SHCBP1 (mouse) GLFLDADPCSDQGYH P42
SHCBP1 (rat) GLFQDTDPCSDCGYH P42
S44-p
FQDEDsCsDCsyRDk
0 11
SHCBP1 (human) FQDEDsCsDCsyRDk S44-p
SHCBP1 (mouse) FLDADPCSDQGYHAN S44
SHCBP1 (rat) FQDTDPCSDCGYHAN S44
S47-p
EDsCsDCsyRDkPGs
0 5
SHCBP1 (human) EDsCsDCsyRDkPGs S47-p
SHCBP1 (mouse) ADPCSDQGYHANPGA G47
SHCBP1 (rat) TDPCSDCGYHANPGA G47
Y48-p
DsCsDCsyRDkPGss
0 2
SHCBP1 (human) DsCsDCsyRDkPGss Y48-p
SHCBP1 (mouse) DPCSDQGYHANPGAT Y48
SHCBP1 (rat) DPCSDCGYHANPGAT Y48
K51-ub
sDCsyRDkPGssLQS
0 3
SHCBP1 (human) sDCsyRDkPGssLQS K51-ub
SHCBP1 (mouse) SDQGYHANPGATVKT N51
SHCBP1 (rat) SDCGYHANPGATVKT N51
S54-p
syRDkPGssLQSFMP
0 3
SHCBP1 (human) syRDkPGssLQSFMP S54-p
SHCBP1 (mouse) GYHANPGATVKTLIP A54
SHCBP1 (rat) GYHANPGATVKTLMP A54
S55-p
yRDkPGssLQSFMPE
0 2
SHCBP1 (human) yRDkPGssLQSFMPE S55-p
SHCBP1 (mouse) YHANPGATVKTLIPE T55
SHCBP1 (rat) YHANPGATVKTLMPE T55
K64-sm
QSFMPEGkTFFPEIF
0 1
SHCBP1 (human) QSFMPEGkTFFPEIF K64-sm
SHCBP1 (mouse) KTLIPEGKTPFPRII K64
SHCBP1 (rat) KTLMPEGKILFPQII K64
Y85-p
FYERFRAyQDyILAD
0 1
SHCBP1 (human) FYERFRAyQDyILAD Y85-p
SHCBP1 (mouse) FYERFRAYQDYILAD Y85
SHCBP1 (rat) FYERFRAYQDYILAD Y85
Y88-p
RFRAyQDyILADCkA
0 1
SHCBP1 (human) RFRAyQDyILADCkA Y88-p
SHCBP1 (mouse) RFRAYQDYILADCKA Y88
SHCBP1 (rat) RFRAYQDYILADCKA Y88
K94-ub
DyILADCkAsEVQEF
0 2
SHCBP1 (human) DyILADCkAsEVQEF K94-ub
SHCBP1 (mouse) DYILADCKASEVKEF K94
SHCBP1 (rat) DYILADCKASEVKEF K94
S96-p
ILADCkAsEVQEFTA
0 1
SHCBP1 (human) ILADCkAsEVQEFTA S96-p
SHCBP1 (mouse) ILADCKASEVKEFTV S96
SHCBP1 (rat) ILADCKASEVKEFTV S96
K108-ub
FTAEFLEkVLEPSGW
0 1
SHCBP1 (human) FTAEFLEkVLEPSGW K108-ub
SHCBP1 (mouse) FTVSFLEKVLEPSGW K108
SHCBP1 (rat) FTVSFLEKVLEPSGW K108
K139-ub
DVDFAALkAVVRLAE
0 4
SHCBP1 (human) DVDFAALkAVVRLAE K139-ub
SHCBP1 (mouse) NVDFPSLKAVVRLAE K139
SHCBP1 (rat) NVDFAALKAVVKLAE K139
K169-ub
MKELLDLkEHRLPLQ
0 3
SHCBP1 (human) MKELLDLkEHRLPLQ K169-ub
SHCBP1 (mouse) VKELLDLKEFHLPLQ K169
SHCBP1 (rat) VKELLDLKEFHLPLQ K169
Y217-p
DEEEEDEyDyFVRCV
0 3
SHCBP1 (human) DEEEEDEyDyFVRCV Y217-p
SHCBP1 (mouse) DEEEEDEyDYFVRCV Y217-p
SHCBP1 (rat) DEEEEDEYDYFVRCV Y217
Y219-p
EEEDEyDyFVRCVEP
0 1
SHCBP1 (human) EEEDEyDyFVRCVEP Y219-p
SHCBP1 (mouse) EEEDEyDYFVRCVEP Y219
SHCBP1 (rat) EEEDEYDYFVRCVEP Y219
S273-p
SSLSNCNsDsEQENI
Upstream
Downstream
2 8
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell cycle regulation
  • cell growth, induced
  • cell motility, induced
Treatment
  • EGF
SHCBP1 (human) SSLSNCNsDsEQENI S273-p
SHCBP1 (mouse) SSLSNCNSDSEQENI S273
SHCBP1 (rat) SSLSSCNSDSEQENI S273
S275-p
LSNCNsDsEQENISM
0 3
SHCBP1 (human) LSNCNsDsEQENISM S275-p
SHCBP1 (mouse) LSNCNSDSEQENISM S275
SHCBP1 (rat) LSSCNSDSEQENISM S275
K287-ub
ISMVEGLkLySEMEQ
0 1
SHCBP1 (human) ISMVEGLkLySEMEQ K287-ub
SHCBP1 (mouse) ISMVEGLNLYSEIEQ N287
SHCBP1 (rat) ISMVEGLNLYSEIEQ N287
Y289-p
MVEGLkLySEMEQLk
0 1
SHCBP1 (human) MVEGLkLySEMEQLk Y289-p
SHCBP1 (mouse) MVEGLNLYSEIEQLK Y289
SHCBP1 (rat) MVEGLNLYSEIEQLK Y289
K296-ub
ySEMEQLkQKLkLIE
0 3
SHCBP1 (human) ySEMEQLkQKLkLIE K296-ub
SHCBP1 (mouse) YSEIEQLKQKLKLIE K296
SHCBP1 (rat) YSEIEQLKQKLKLIE K296
K300-ub
EQLkQKLkLIENPLL
0 4
SHCBP1 (human) EQLkQKLkLIENPLL K300-ub
SHCBP1 (mouse) EQLKQKLKLIENPLL K300
SHCBP1 (rat) EQLKQKLKLIENPLL K300
Y313-p
LLRYVFGyQkNSNIQ
0 2
SHCBP1 (human) LLRYVFGyQkNSNIQ Y313-p
SHCBP1 (mouse) LLRYVFGYQKNSNIQ Y313
SHCBP1 (rat) LLRYVFGYQKNSNIQ Y313
K315-ub
RYVFGyQkNSNIQAk
Upstream
0 8
Treatment
  • MG132
SHCBP1 (human) RYVFGyQkNSNIQAk K315-ub
SHCBP1 (mouse) RYVFGYQKNSNIQGK K315
SHCBP1 (rat) RYVFGYQKNSNIQAK K315
K322-ub
kNSNIQAkGVRSSGQ
0 1
SHCBP1 (human) kNSNIQAkGVRSSGQ K322-ub
SHCBP1 (mouse) KNSNIQGKGTRQNGQ K322
SHCBP1 (rat) KNSNIQAKGTRQNGQ K322
K419-ub
IVIEKRGkGDTFVDC
0 7
SHCBP1 (human) IVIEKRGkGDTFVDC K419-ub
SHCBP1 (mouse) IVIEKRGKGDTFVDC K419
SHCBP1 (rat) IIIEKRGKGDTFVDC K419
K432-ub
DCTGADIkISGIKFV
0 1
SHCBP1 (human) DCTGADIkISGIKFV K432-ub
SHCBP1 (mouse) DCTGMDVKISGIKFI K432
SHCBP1 (rat) DCTGMDVKISGVKFI K432
K454-ub
ILIVHRGkTTLENCV
0 1
SHCBP1 (human) ILIVHRGkTTLENCV K454-ub
SHCBP1 (mouse) ILIIHHGKTTLENCV K454
SHCBP1 (rat) ILIIHHGKTTLENCV K454
S474-p
TGVTVRTsAEFLMkN
0 1
SHCBP1 (human) TGVTVRTsAEFLMkN S474-p
SHCBP1 (mouse) TGVTVRTSAELFMKN S474
SHCBP1 (rat) TGVTVRTSAELFMKN S474
K480-ub
TsAEFLMkNSDLYGA
0 3
SHCBP1 (human) TsAEFLMkNSDLYGA K480-ub
SHCBP1 (mouse) TSAELFMKNSDVYGA K480
SHCBP1 (rat) TSAELFMKNSDVYGA K480
K488-ub
NSDLYGAkGAGIEIY
0 2
SHCBP1 (human) NSDLYGAkGAGIEIY K488-ub
SHCBP1 (mouse) NSDVYGAKGAGIEIY K488
SHCBP1 (rat) NSDVYGAKGAGIEIY K488
K511-ub
DNGIHHCkEGILIkD
0 1
SHCBP1 (human) DNGIHHCkEGILIkD K511-ub
SHCBP1 (mouse) DNGIHHCKEGILIKD K511
SHCBP1 (rat) DNGIHHCKEGILIKD K511
K517-ub
CkEGILIkDFLDEHY
0 2
SHCBP1 (human) CkEGILIkDFLDEHY K517-ub
SHCBP1 (mouse) CKEGILIKDFLDEHY K517
SHCBP1 (rat) CKEGILIKDFLDEHY K517
K548-ub
GYGVVLVkPTIFSDL
0 1
SHCBP1 (human) GYGVVLVkPTIFSDL K548-ub
SHCBP1 (mouse) GYGVVLVKPTIFCDL K548
SHCBP1 (rat) GYGVVLVKPTIFCDL K548
K567-sm
EDGTEENkALkIQTs
0 1
SHCBP1 (human) EDGTEENkALkIQTs K567-sm
SHCBP1 (mouse) QDEINDNMVQKNKEA M567
SHCBP1 (rat) QDETNDNTVQKNKEA T567
K570-ub
TEENkALkIQTsGEP
0 1
SHCBP1 (human) TEENkALkIQTsGEP K570-ub
SHCBP1 (mouse) gap -
SHCBP1 (rat) TNDNTVQKNKEADVT K570
S574-p
kALkIQTsGEPDVAE
Upstream
0 1
Treatment
  • BI2536
SHCBP1 (human) kALkIQTsGEPDVAE S574-p
SHCBP1 (mouse) NDNMVQKNKEADVTE N571
SHCBP1 (rat) NDNTVQKNKEADVTE N571
K595-ub
LIECATGkMELCART
0 1
SHCBP1 (human) LIECATGkMELCART K595-ub
SHCBP1 (mouse) MLQCVASKMEPYATA K592
SHCBP1 (rat) MLQCVSNKMEPYATA K592
S622-p
VNELIAAsTQkGQIK
0 1
SHCBP1 (human) VNELIAAsTQkGQIK S622-p
SHCBP1 (mouse) INELLAISMQKGRMK S619
SHCBP1 (rat) INELLAISMQKGRMK S619
K625-ub
LIAAsTQkGQIKKKR
0 1
SHCBP1 (human) LIAAsTQkGQIKKKR K625-ub
SHCBP1 (mouse) LLAISMQKGRMKKRL K622
SHCBP1 (rat) LLAISMQKGRMKKRL K622
S634-p
QIKKKRLsELGITQA
Upstream
Downstream
1 9
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • AurB (human)
Putative in vivo kinases:
  • AurB (human)
Treatment
  • BI2536
  • CIAP
  • nocodazole
  • VX-680
view more >
SHCBP1 (human) QIKKKRLsELGITQA S634-p
SHCBP1 (mouse) GRMKKRLSELGITQA S630
SHCBP1 (rat) GRMKKRLSELGIVQA S630
S647-p
QADDNLMsQEMFVGI
0 1
SHCBP1 (human) QADDNLMsQEMFVGI S647-p
SHCBP1 (mouse) QADDNIMSQEMFIEI S643
SHCBP1 (rat) QADDDLMSQEMFIEI S643